Rachel Koelmeyer

1.3k total citations
31 papers, 721 citations indexed

About

Rachel Koelmeyer is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Rachel Koelmeyer has authored 31 papers receiving a total of 721 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Rheumatology, 14 papers in Immunology and 5 papers in Hematology. Recurrent topics in Rachel Koelmeyer's work include Systemic Lupus Erythematosus Research (15 papers), Atherosclerosis and Cardiovascular Diseases (9 papers) and T-cell and B-cell Immunology (6 papers). Rachel Koelmeyer is often cited by papers focused on Systemic Lupus Erythematosus Research (15 papers), Atherosclerosis and Cardiovascular Diseases (9 papers) and T-cell and B-cell Immunology (6 papers). Rachel Koelmeyer collaborates with scholars based in Australia, United States and Germany. Rachel Koelmeyer's co-authors include Alberta Hoi, Eric F. Morand, Jeffrey Grierson, Rangi Kandane‐Rathnayake, Fabien B. Vincent, James Harris, Pritinder Kaur, Anthony M. A. Smith, Andrew C.W. Zannettino and Holger Schlüter and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Cancer.

In The Last Decade

Rachel Koelmeyer

30 papers receiving 714 citations

Peers

Countries citing papers authored by Rachel Koelmeyer

Since Specialization

Citations

This map shows the geographic impact of Rachel Koelmeyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Koelmeyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Koelmeyer more than expected).

Fields of papers citing papers by Rachel Koelmeyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Koelmeyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Koelmeyer. The network helps show where Rachel Koelmeyer may publish in the future.

Co-authorship network of co-authors of Rachel Koelmeyer

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Koelmeyer. A scholar is included among the top collaborators of Rachel Koelmeyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Koelmeyer. Rachel Koelmeyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Type 1 interferon status in systemic lupus erythematosus: a longitudinal analysis 2022 ·Lupus Science & Medicine ·Melissa Northcott, Sarah A. Jones, Rachel Koelmeyer, (unknown), Fabien B. Vincent, Rangi Kandane‐Rathnayake, Alberta Hoi, Eric F. Morand	39
2	Immunosuppressant exposure confounds gene expression analysis in systemic lupus erythematosus 2022 ·Frontiers in Immunology ·Melissa Northcott, Linden J. Gearing, (unknown), Rachel Koelmeyer, Alberta Hoi, Paul J. Hertzog, Eric F. Morand	6
3	Predictors of infection requiring hospitalization in patients with systemic lupus erythematosus: a time-to-event analysis 2022 ·Seminars in Arthritis and Rheumatism ·(unknown), Rachel Koelmeyer, Ning Li, (unknown), Ai Li Yeo, (unknown), (unknown), Vera Golder, A. Richard Kitching, Eric F. Morand, Alberta Hoi	13
4	The performance of different classification criteria for systemic lupus erythematosus in a real-world rheumatology department 2022 ·Lara D. Veeken ·(unknown), (unknown), (unknown), Rachel Koelmeyer, Alberta Hoi	13
5	Disease course following High Disease Activity Status revealed patterns in SLE 2021 ·Arthritis Research & Therapy ·Alberta Hoi, Rachel Koelmeyer, (unknown), Ying Sun, Amy Kao, Oliver Günther, Hieu T. Nim, Eric F. Morand	4
6	Algorithm for calculating high disease activity in SLE 2021 ·Lara D. Veeken ·Alberta Hoi, Hieu T. Nim, Rachel Koelmeyer, (unknown), Amy Kao, Oliver Günther, Eric F. Morand	7
7	Novel Methods of Incorporating Time in Longitudinal Multivariate Analysis Reveals Hidden Associations With Disease Activity in Systemic Lupus Erythematosus 2019 ·Frontiers in Immunology ·Hieu T. Nim, Kathryn Connelly, Fabien B. Vincent, François Petitjean, Alberta Hoi, Rachel Koelmeyer, Sarah Boyd, Eric F. Morand	4
8	Analysis of serum B cell‐activating factor from the tumor necrosis factor family (BAFF) and its soluble receptors in systemic lupus erythematosus 2019 ·Clinical & Translational Immunology ·Fabien B. Vincent, Rangi Kandane‐Rathnayake, Rachel Koelmeyer, Alberta Hoi, James Harris, Fabienne Mackay, Eric F. Morand	25
9	The Rare Anaphylaxis-Associated FcγRIIa3 Exhibits Distinct Characteristics From the Canonical FcγRIIa1 2018 ·Frontiers in Immunology ·(unknown), Halina M. Trist, Catherine S. Palmer, Peck Szee Tan, Betty Kouskousis, Alicia M. Chenoweth, Stephen J. Kent, Graham A. Mackay, Alberta Hoi, Rachel Koelmeyer, C Slade, Vanessa L. Bryant, Philip D. Hodgkin, Pei M. Aui, Menno C. van Zelm, Bruce D. Wines, P. Mark Hogarth	7
10	Analysis of Serum Interleukin (IL)-1β and IL-18 in Systemic Lupus Erythematosus 2018 ·Frontiers in Immunology ·(unknown), Fabien B. Vincent, Rangi Kandane‐Rathnayake, Rachel Koelmeyer, Emily Lin, Janet Chang, Alberta Hoi, Eric F. Morand, James Harris, Tali Lang	92
11	Diabetes in young adult men: social and health-related correlates 2016 ·BMC Public Health ·Rachel Koelmeyer, Shyamali C. Dharmage, Dallas R. English	9
12	Age Matters: Exploring Correlates of Self-Rated Health Across Four Generations of Australian Males 2016 ·Behavioral Medicine ·Rachel Koelmeyer, Dianne Currier, Matthew J. Spittal, Marisa Schlichthorst, Jane Pirkis, Dallas R. English	3
13	Cohort Profile:Ten to Men(the Australian Longitudinal Study on Male Health) 2016 ·International Journal of Epidemiology ·Jane Pirkis, Dianne Currier, John B. Carlin, Louisa Degenhardt, Shyamali C. Dharmage, Billie Giles‐Corti, Ian Gordon, Lyle C. Gurrin, Jane S. Hocking, Anne Kavanagh, Louise Keogh, Rachel Koelmeyer, Anthony D. LaMontagne, George Patton, Lena Sanci, Matthew J. Spittal, Marisa Schlichthorst, David M. Studdert, Joanne Williams, Dallas R. English	31
14	Association of social determinants of health with self-rated health among Australian gay and bisexual men living with HIV 2013 ·AIDS Care ·Rachel Koelmeyer, Dallas R. English, (unknown), Jeffrey Grierson	8
15	Beyond the data: Distinct features and experiences of women living with HIV in Australia 2012 ·Rachel Koelmeyer, Karalyn McDonald, Jeffrey Grierson	1
16	New Frontiers: Exploring the Psychosocial Challenges of Growing Old with HIV 2010 ·Anthony Lyons, Rachel Koelmeyer, Jeffrey Grierson, Marian Pitts	1
17	A role for pericytes as microenvironmental regulators of human skin tissue regeneration 2009 ·Journal of Clinical Investigation ·Sophie Paquet‐Fifield, Holger Schlüter, Amy Li, (unknown), Pradnya Gangatirkar, Daniel Blashki, Rachel Koelmeyer, Normand Pouliot, Manuela Palatsides, Sarah Ellis, Nathalie Brouard, Andrew C.W. Zannettino, Nicholas A. Saunders, (unknown), Jason Li, Pritinder Kaur	167
18	A Prospective Multicenter Trial of Peripheral Blood Stem Cell Sibling Allografts for Acute Myeloid Leukemia in First Complete Remission Using Fludarabine-Cyclophosphamide Reduced Intensity Conditioning 2007 ·Biology of Blood and Marrow Transplantation ·Andrew Grigg, John Gibson, Peter Bardy, John Reynolds, Paul Shuttleworth, Rachel Koelmeyer, Jeff Szer, Andrew W. Roberts, Luen Bik To, Glen Kennedy, Ken Bradstock	20
19	Efficacy and safety of imatinib in patients with chronic myeloid leukemia and complete or near‐complete cytogenetic response to interferon‐α 2007 ·Cancer ·Susan Branford, Timothy P. Hughes, Alvin Milner, Rachel Koelmeyer, Anthony P. Schwarer, Chris Arthur, Robin Filshie, (unknown), Kevin Lynch, Kerry Taylor	7
20	Insulin-like growth factor binding protein-3 (IGFBP-3) localizes to and modulates proliferative epidermal keratinocytes in vivo 2005 ·British Journal of Dermatology ·Stephanie R. Edmondson, (unknown), Pritinder Kaur, (unknown), Rachel Koelmeyer, Albert P. Li, Josef V. Silha, Liam J. Murphy, Christopher J. Wraight, George A. Werther	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact